Diethylstilbestrol Injection |
Stilphostrol Injection |
Clinical Trial: A Study to Determine the Effectiveness and Safety of Risperidone in the Prevention of Bipolar Mood Episodes
This study is currently recruiting patients.
Verified by Johnson & Johnson Pharmaceutical Research & Development, L.L.C. August 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Bipolar Disorder | Drug: Risperidone Long Acting Injection | Phase III |
MedlinePlus related topics: Bipolar Disorder
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Official Title: A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Risperidone Long-Acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar 1 Disorder, with Open-Label Extension
Study start: January 2005
Eligibility
Inclusion Criteria:
- Diagnosis of bipolar I disorder, currently experiencing a mixed or manic episode or stable,
- Two or more bipolar mood episodes in the last 2 years excluding current episode
- Females must have a negative pregnancy test
Exclusion Criteria:
- History of more that 4 mood episodes a year during the last two years
- Experiencing a depressive episode
- Antisocial or borderline personality disorder
- Has unstable or serious general medical illness
- Has received medications disallowed by study criteria
Location and Contact Information
California
National City, California, United States; Recruiting
Oceanside, California, United States; Recruiting
District of Columbia
Washington, District of Columbia, 20016, United States; Recruiting
Florida
Hialeah, Florida, 30016, United States; Recruiting
Brandenton, Florida, United States; Recruiting
Louisiana
Lake Charles, Louisiana, 70601, United States; Recruiting
New Jersey
Clementon, New Jersey, United States; Recruiting
Oklahoma
Oklahoma City, Oklahoma, 73103, United States; Recruiting
Texas
Desoto, Texas, 75115, United States; Recruiting
Virginia
Richmond, Virginia, United States; Recruiting
Washington
Seattle, Washington, 98133, United States; Recruiting
Austria
Peishingerstrasse, Austria; Recruiting
Voecklabruck, Austria; Recruiting
India, Hyderabad
Banjara Hills, Hyderabad, 500 034, India; Recruiting
India, Manipal
Karnataka, Manipal, 576104, India; Recruiting
Malaysia
Tampoi, Malaysia; Recruiting
Kelantan, Malaysia; Recruiting
Kuala Lumpur, Malaysia; Recruiting
Poland
Gdansk, Poland; Recruiting
Choroszcz, Poland; Recruiting
Swiecie, Poland; Recruiting
Lipno, Poland; Recruiting
Tuszyn, Poland; Recruiting
Lodz, Poland; Recruiting
Russian Federation
Leningradsky Region, Russian Federation; Recruiting
Moscow, Russian Federation; Recruiting
St Petersburg, Russian Federation; Recruiting
Moscow, Russian Federation; Recruiting
SARATOV, Russian Federation; Recruiting
St Petersburg, Russian Federation; Recruiting
Samara, Russian Federation; Recruiting
Moscow, Russian Federation; Recruiting
St Petersburg, Russian Federation; Recruiting
Moscow, Russian Federation; Recruiting
Slovakia
Slovak Republic, Slovakia; Recruiting
Rimavska Sobota, Slovakia; Recruiting
Slovakia, Slovak Republic
Bratislava, Slovak Republic, Slovakia; Recruiting
Spain
Madrid, Spain; Recruiting
Barcelona, Spain; Recruiting
Taiwan
Tainan, Taiwan; Recruiting
Kuei-San,Tao-yuan, Taiwan; Recruiting
Taipei, Taiwan; Recruiting
Taichung, Taiwan; Recruiting
Ukraine
Dnepropetrvsk, Ukraine; Recruiting
Lvov, Ukraine; Recruiting
Simferopol, Ukraine; Recruiting
Dnepropetrovsk, Ukraine; Recruiting
Kiev, Ukraine; Recruiting
Odessa, Ukraine; Recruiting
Kharkov, Ukraine; Recruiting
More Information
Last Updated: August 19, 2005
Record first received: June 30, 2005
ClinicalTrials.gov Identifier: NCT00132678
Health Authority: United States: Food and Drug Administration; European Union: European Medicines Agency
ClinicalTrials.gov processed this record on 2005-08-23
Resources
- Diethylstilbestrol Injection (Drug Digest)
- Stilphostrol Injection (Drug Digest)

Not Signed In -


